BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 30805950)

  • 1. Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis.
    Hara K; Takeda A; Tsurugai Y; Saigusa Y; Sanuki N; Eriguchi T; Maeda S; Tanaka K; Numata K
    Hepatology; 2019 Jun; 69(6):2533-2545. PubMed ID: 30805950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.
    Chen PH; Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Chao Y; Lin HC; Wu JC
    Ann Hepatol; 2013; 12(2):263-73. PubMed ID: 23396738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
    Wahl DR; Stenmark MH; Tao Y; Pollom EL; Caoili EM; Lawrence TS; Schipper MJ; Feng M
    J Clin Oncol; 2016 Feb; 34(5):452-9. PubMed ID: 26628466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Facciorusso A; Del Prete V; Antonino M; Crucinio N; Neve V; Di Leo A; Carr BI; Barone M
    Dig Liver Dis; 2014 Nov; 46(11):1014-9. PubMed ID: 25085684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
    Takayasu K; Arii S; Sakamoto M; Matsuyama Y; Kudo M; Kaneko S; Nakashima O; Kadoya M; Izumi N; Takayama T; Ku Y; Kumada T; Kubo S; Kokudo T; Hagiwara Y; Kokudo N;
    Liver Int; 2018 Mar; 38(3):484-493. PubMed ID: 29266722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma.
    Kim N; Kim HJ; Won JY; Kim DY; Han KH; Jung I; Seong J
    Radiother Oncol; 2019 Feb; 131():81-87. PubMed ID: 30773192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic versus open radiofrequency ablation for treatment of small hepatocellular carcinoma.
    Sakoda M; Ueno S; Iino S; Minami K; Ando K; Kawasaki Y; Kurahara H; Mataki Y; Maemura K; Shinchi H; Natsugoe S
    World J Surg; 2013 Mar; 37(3):597-601. PubMed ID: 23192169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
    Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
    Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical resection versus radiofrequency ablation very early-stage HCC (≤2 cm Single HCC): A propensity score analysis.
    Chu HH; Kim JH; Kim PN; Kim SY; Lim YS; Park SH; Ko HK; Lee SG
    Liver Int; 2019 Dec; 39(12):2397-2407. PubMed ID: 31549771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of percutaneous radiofrequency ablation and CyberKnife(®) for initial solitary hepatocellular carcinoma: A pilot study.
    Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kishimoto Y; Okubo Y; Makino H; Tsukamoto N; Igarashi Y; Sumino Y
    World J Gastroenterol; 2015 Dec; 21(48):13490-9. PubMed ID: 26730160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.
    Parikh ND; Marshall VD; Green M; Lawrence TS; Razumilava N; Owen D; Singal AG; Feng M
    J Med Imaging Radiat Oncol; 2018 Oct; 62(5):673-681. PubMed ID: 29877615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
    Wang JH; Wang CC; Hung CH; Chen CL; Lu SN
    J Hepatol; 2012 Feb; 56(2):412-8. PubMed ID: 21756858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.